| P2093 | author name string | Jörg Jerosch | |
| P2860 | cites work | Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence | Q21195656 |
| | Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial | Q39871697 |
| | Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner | Q40106311 |
| | Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells | Q40133543 |
| | Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene | Q41833959 |
| | Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. | Q42541481 |
| | Synovial tissue inflammation in early and late osteoarthritis | Q43048512 |
| | Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis | Q43276199 |
| | Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis | Q43546528 |
| | Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis | Q43873300 |
| | The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study | Q44097220 |
| | Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers | Q44163866 |
| | Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes | Q44394411 |
| | Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress | Q44439622 |
| | The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants | Q45711565 |
| | Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through proline rich tyrosine kinase 2, c-src, NF-kappaB and protein kinase Cdelta. | Q46028651 |
| | Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. | Q46106596 |
| | Modification of the composition of articular cartilage collagen fibrils with increasing age. | Q46259243 |
| | Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial | Q46321177 |
| | The complex pathology of osteoarthritis: even mitochondria are involved | Q46453970 |
| | Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants | Q46480686 |
| | Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial | Q46746770 |
| | Differing results of trials of glucosamine for pain in arthritis: comment on the article by VLAD et al. | Q46830088 |
| | Marginal efficacy of glucosamine: comment on the article by VLAD et al and the editorial by Reginster | Q46830098 |
| | Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs | Q47209677 |
| | Chronic stress tolerance levels for human articular cartilage: two nonuniform contact models applied to long-term follow-up of CDH. | Q48541282 |
| | Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study | Q48592216 |
| | Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation | Q22000860 |
| | Glucosamine therapy for treating osteoarthritis | Q24244026 |
| | The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial | Q24630475 |
| | Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system | Q24647595 |
| | EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) | Q24674132 |
| | Obesity and osteoarthritis: more complex than predicted! | Q24675065 |
| | Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function | Q24804197 |
| | Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis | Q24805523 |
| | Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1 | Q24816719 |
| | Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production | Q28115730 |
| | Matrix metalloproteinases | Q28140451 |
| | Free radicals, antioxidants, and nutrition | Q28205310 |
| | Collagen Synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of Glucosamine HCl and chondroitin sulfate | Q28212371 |
| | Do glucosamine and chondroitin treat the symptoms of osteoarthritis? | Q28354361 |
| | Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | Q28374250 |
| | Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis | Q28943498 |
| | A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort | Q29394573 |
| | Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. | Q30836366 |
| | Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey | Q30990480 |
| | Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial | Q32050561 |
| | Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes | Q32067938 |
| | Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo | Q33199633 |
| | Osteoarthritis: a metabolic disease induced by local abnormal leptin activity? | Q33212755 |
| | Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials | Q33214439 |
| | Clinical review of chondroitin sulfate in osteoarthritis | Q33357124 |
| | Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. A review. | Q33366624 |
| | Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants | Q33368886 |
| | The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis | Q33422129 |
| | Evaluation of the effect of antiarthritic drugs on the secretion of proteoglycans by lapine chondrocytes using a novel assay procedure | Q33561663 |
| | Effects of fish oil supplementation in rheumatoid arthritis | Q33562342 |
| | Genetics of osteoarthritis | Q33579265 |
| | Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. | Q50478261 |
| | Metabolic and ultrastructural changes in articular cartilage of rats fed dietary supplements of omega-3 fatty acids. | Q50879603 |
| | Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? | Q51033276 |
| | Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. | Q51161871 |
| | 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. | Q51706290 |
| | A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. | Q55033577 |
| | The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. | Q55044134 |
| | Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism | Q56169415 |
| | Sex and ethnic differences in the association ofASPN,CALM1,COL2A1,COMP, andFRZB with genetic susceptibility to osteoarthritis of the knee | Q57445849 |
| | Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis | Q61830864 |
| | Metabolic fate of exogenous chondroitin sulfate in the experimental animal | Q67294092 |
| | Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture | Q67754603 |
| | Failure of selenium-ace to improve osteoarthritis | Q68519878 |
| | Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study | Q70168695 |
| | The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study | Q70661807 |
| | Omega-3 fatty acids enhance ligament fibroblast collagen formation in association with changes in interleukin-6 production | Q73348681 |
| | Inflammation is a feature of the disease process in early knee joint osteoarthritis | Q73574859 |
| | The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2 | Q74279990 |
| | Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes | Q74430431 |
| | Quantitative structural organization of normal adult human articular cartilage | Q74486244 |
| | Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13 | Q74714921 |
| | ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status | Q77105435 |
| | Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate | Q78444082 |
| | Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis | Q79345643 |
| | Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis | Q79467035 |
| | Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation | Q79872147 |
| | Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis | Q80707124 |
| | Chondrocyte senescence, joint loading and osteoarthritis | Q80851787 |
| | Osteoarthritis | Q81042522 |
| | Glucosamine therapy for osteoarthritis: an update | Q81042715 |
| | Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial | Q81484755 |
| | Knee structural alteration and BMI: a cross-sectional study | Q81596030 |
| | Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes | Q82607594 |
| | The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate | Q95305820 |
| | The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination | Q33679221 |
| | NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments | Q33992822 |
| | Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 |
| | Dietary supplements for osteoarthritis. | Q34009777 |
| | Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis | Q34214244 |
| | Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets | Q34283578 |
| | Risk factors for osteoarthritis: genetics | Q34286731 |
| | Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses | Q34383021 |
| | Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis | Q34510491 |
| | N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes | Q34514554 |
| | Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway | Q34520479 |
| | Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study | Q34528067 |
| | Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes | Q34534426 |
| | The role of reactive oxygen species in homeostasis and degradation of cartilage | Q34537354 |
| | Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies | Q34546341 |
| | Risk assessment for glucosamine and chondroitin sulfate | Q34570456 |
| | Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator | Q34574562 |
| | Current role of glucosamine in the treatment of osteoarthritis. | Q34578263 |
| | Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. | Q34581685 |
| | Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22(Phox) and iNOS expression. | Q34586059 |
| | Glucosamine for pain in osteoarthritis: why do trial results differ? | Q34643259 |
| | Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis | Q34656760 |
| | Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine | Q34752761 |
| | Glucosamine | Q34816926 |
| | Review article: Glucosamine | Q34978110 |
| | Nutritional management of rheumatoid arthritis: a review of the evidence | Q35093729 |
| | Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study | Q35638607 |
| | The effect of nutritional supplements on osteoarthritis | Q35896687 |
| | Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention | Q36171836 |
| | Aggrecan, aging and assembly in articular cartilage. | Q36249555 |
| | Matrix metalloproteinases: role in arthritis | Q36251020 |
| | The effects of exercise on human articular cartilage | Q36459463 |
| | Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial | Q36464778 |
| | Genetic influences on osteoarthritis in women: a twin study | Q36598099 |
| | Cellular, molecular, and matrix changes in cartilage during aging and osteoarthritis | Q36691025 |
| | Low-selenium diet, bone, and articular cartilage in rats. | Q36698619 |
| | Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis | Q36736328 |
| | Osteoarthritis: aging of matrix and cells--going for a remedy | Q36737794 |
| | TGF-beta and osteoarthritis | Q36773157 |
| | Osteoarthritis in 2007. | Q36964888 |
| | Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management | Q37001372 |
| | Adipokines as emerging mediators of immune response and inflammation. | Q37014112 |
| | ADAMTS-5: the story so far. | Q37076199 |
| | Cartilage in normal and osteoarthritis conditions | Q37154103 |
| | Potential effects of chondroitin sulfate on joint swelling: a GAIT report | Q37167150 |
| | Developments in the clinical understanding of osteoarthritis | Q37207005 |
| | Articular cartilage: structure, injuries and review of management | Q37234022 |
| | Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance | Q37267822 |
| | Osteoarthritis: a tale of three tissues. | Q37304243 |
| | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | Q37310621 |
| | Obesity and the musculoskeletal system | Q37354006 |
| | Glucosamine and chondroitin for osteoarthritis | Q37354339 |
| | Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. | Q37400435 |
| | Does knee malalignment increase the risk of development and progression of knee osteoarthritis? A systematic review | Q37427642 |
| | A metabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. | Q37497607 |
| | The effects of oral glucosamine on joint health: is a change in research approach needed? | Q37592565 |
| | Obesity and inflammation--targets for OA therapy. | Q37701900 |
| | The effects of contact pressure elevations and aseptic necrosis on the long-term outcome of congenital hip dislocation. | Q38095759 |
| | Human articular chondrocytes express functional leptin receptors | Q38297153 |
| | Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism | Q38303866 |
| | Evidence for a key role of leptin in osteoarthritis | Q38348145 |
| | Cartilage contact pressure elevations in dysplastic hips: a chronic overload model | Q39103446 |
| | Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis | Q39429209 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | fatty acid | Q61476 |
| | glucosamine | Q32907954 |
| P304 | page(s) | 969012 | |
| P577 | publication date | 2011-08-02 | |
| P1433 | published in | International journal of rheumatology | Q26853833 |
| P1476 | title | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids | |
| P478 | volume | 2011 | |